Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Monday's Pre-Market Session

Author: Benzinga Insights | November 13, 2023 09:06am

Gainers

  • Tivic Health Systems (NASDAQ:TIVC) shares rose 116.8% to $2.58 during Monday's pre-market session. The company's market cap stands at $3.7 million.
  • SenesTech (NASDAQ:SNES) stock rose 65.78% to $0.4. The company's market cap stands at $1.2 million. The company's, Q3 earnings came out 2 days ago.
  • ZyVersa Therapeutics (NASDAQ:ZVSA) stock increased by 20.66% to $0.08. The market value of their outstanding shares is at $3.4 million.
  • Cingulate (NASDAQ:CING) stock moved upwards by 20.59% to $0.38. The market value of their outstanding shares is at $6.6 million.
  • Addex Therapeutics (NASDAQ:ADXN) stock rose 15.63% to $6.5. The company's market cap stands at $5.3 million.
  • Biora Therapeutics (NASDAQ:BIOR) stock moved upwards by 14.78% to $1.63. The company's market cap stands at $38.0 million. As per the press release, Q3 earnings came out today.

Losers

  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares decreased by 89.2% to $0.42 during Monday's pre-market session. The company's market cap stands at $3.9 million.
  • Aclaris Therapeutics (NASDAQ:ACRS) stock fell 85.6% to $0.68. The market value of their outstanding shares is at $48.5 million.
  • Verve Therapeutics (NASDAQ:VERV) stock declined by 31.53% to $10.75. The market value of their outstanding shares is at $685.3 million. As per the news, the Q3 earnings report came out 4 days ago.
  • TRACON Pharma (NASDAQ:TCON) shares decreased by 16.33% to $0.19. The market value of their outstanding shares is at $5.9 million. As per the press release, Q3 earnings came out 2 days ago.
  • Monopar Therapeutics (NASDAQ:MNPR) shares declined by 15.22% to $0.31. The company's market cap stands at $4.4 million. As per the press release, Q3 earnings came out 2 days ago.
  • Singular Genomics Sys (NASDAQ:OMIC) stock decreased by 14.67% to $0.32. The market value of their outstanding shares is at $23.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACRS ADXN BIOR CING MNPR OMIC SNES TCBP TCON TIVC VERV ZVSA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist